T. Hibi

发表

Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion

H. Ishii, M. Yamazaki, T. Kanai, 2000, British Journal of Cancer.

Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease.

S. Akira, T. Hibi, M. Ikeda, 2001, Gastroenterology.

Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice.

S. Akira, H. Ogata, K. Takeda, 2003, Scandinavian journal of gastroenterology.

Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase.

M. Kitajima, K. Enomoto, T. Ikeda, 2000, Cancer letters.

Increased formation of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes.

M. Kitajima, K. Enomoto, T. Ikeda, 2000, Cancer letters.

Interferon-inducible gene family 1-8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis.

H. Ogata, T. Hibi, H. Ishii, 1999, Cancer research.

SY1. building the foundation for investigator-initiated clinical trial

P. Jänne, H. Katayama, M. Kudo, 2012 .

Associations of HLA class I alleles in Japanese patients with Crohn’s disease

T. Sasazuki, K. Tsuchiya, J. Umeno, 2014, Genes and Immunity.

Intracellular bacteria recognition contributes to maximal interleukin (IL)‐12 production by IL‐10‐deficient macrophages

T. Kanai, K. Matsuoka, N. Kamada, 2011, Clinical and experimental immunology.

Human intestinal epithelial cell‐derived interleukin (IL)‐18, along with IL‐2, IL‐7 and IL‐15, is a potent synergistic factor for the proliferation of intraepithelial lymphocytes

H. Ogata, M. Ikeda, M. Kurimoto, 2004, Clinical and experimental immunology.

Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa.

H. Ogata, H. Ishii, M. Yamazaki, 1999, Gastroenterology.

Immunoglobulin G subclass distribution of human anticolon antibodies in ulcerative colitis

H. Ishii, S. Aiso, Y. Iwao, 1995, Journal of gastroenterology and hepatology.

Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes.

H. Ishii, S. Aiso, Y. Iwao, 1995, The Journal of clinical investigation.

Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial

T. Matsui, H. Kashida, M. Nojima, 2017, Alimentary pharmacology & therapeutics.

CD45RChighCD4+ intestinal mucosal lymphocytes infiltrating in the inflamed colonic mucosa of a novel rat colitis model induced by TNB immunization.

H. Ishii, M. Yamazaki, T. Suzuki, 1998, Clinical Immunology and Immunopathology.

Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease.

W. Brown, Y. Iwao, Y. Hosoda, 1994, Gut.

Interleukin 2 and interferon-y augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis

H. Ogata, T. Kanai, S. Aiso, 2006 .

In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis.

H. Ogata, Y. Iwao, K. Toda, 1990, Gut.

Cyclosporine for inflammatory bowel disease--an epoch-making therapy for corticosteroid-resistant or dependent patients?

T. Hibi, T. Hisamatsu, 1998, Journal of gastroenterology.

RORγt-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation

T. Kanai, T. Hisamatsu, Y. Mikami, 2012, Mucosal Immunology.

Deletion mapping on chromosome 1p in well-differentiated gastric cancer.

Y. Nakamura, J. Inazawa, T. Nakajima, 1996, British Journal of Cancer.

T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn’s disease

Toshifumi Hibi, Haruhiko Ogata, Mamoru Watanabe, 2004, Gut.

Thymectomy in ulcerative colitis: a report of cases over a 13 year period.

H. Ogata, H. Asakura, S. Aiso, 1991, Thymus.

Predictive factors of response to leukocytapheresis therapy for ulcerative colitis.

H. Ishii, T. Kanai, Y. Iwao, 1998, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

Restricted usage of immunoglobulin heavy chain variable region (VH3) in B cell clones producing anti-colon antibodies in ulcerative colitis

H. Ishii, Mamoru Watanabe, Y. Iwao, 1995 .

Carcinoembryonic antigen mediates in vitro cell aggregation induced by interferon-gamma in a human colon cancer cell line: requirement for active metabolism and intact cytoskeleton.

T. Kanai, S. Aiso, Y. Iwao, 1993, Cancer letters.

[Etiology and treatment of inflammatory bowel diseases. 2. Crohn disease].

Y. Iwao, Y. Hosoda, M. Tsuchiya, 1993, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.

H. Ishii, Y. Iwao, N. Inoue, 1995, Journal of gastroenterology.

Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis

H. Ishii, T. Kanai, M. Mukai, 2000, British Journal of Cancer.

Evaluation of alcohol metabolism in humans using the non-invasive [13C]-ethanol breath test – influence of gender, Helicobacter pylori infection and polymorphism of alcohol-oxidizing enzymes

M. Suematsu, H. Ishii, Hidekazu Suzuki, 2006 .

Distribution and partial characterisation of IgG Fc binding protein in various mucin producing cells and body fluids

H. Ogata, T. Hibi, T. Yoshida, 2002, Gut.

Preferential activation of CD4+V beta 5.2/5.3+ intestinal intraepithelial lymphocytes in the inflamed lesions of Crohn's disease.

H. Ishii, Y. Iwao, Y. Hosoda, 1996, Clinical immunology and immunopathology.